Immunosuppressive therapy of myasthenia gravis.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D005260:Female; D006386:Hemagglutination Tests; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy* / Q000276:immunology; D012075:Remission, Spontaneous; D012217:Rheumatoid Factor / Q000032:analysis
D000974:Antibodies, Antinuclear; D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D012217:Rheumatoid Factor